Ozempic, Wegovy, and compounded semaglutide are often discussed as if they are the same product. They are not. Ozempic and Wegovy are FDA-approved brand-name medications that contain semaglutide. Compounded semaglutide is prepared by a licensed compounding pharmacy for an individual patient and is not FDA-approved. The right option depends on your health history, treatment goals, eligibility, access, and your clinician’s judgment.
What Is Semaglutide?
Semaglutide is a GLP-1 receptor agonist. It acts like a natural hormone involved in appetite, digestion, and blood sugar control. Research suggests it may help some patients feel full sooner and experience fewer cravings when used with healthy eating, physical activity, and medical guidance.
Although Ozempic and Wegovy contain semaglutide, they have different FDA-approved uses, dosing schedules, and delivery options. They should not be treated as interchangeable without guidance from a qualified medical provider.
What Is Ozempic?
Ozempic is an FDA-approved prescription medication for adults with type 2 diabetes. It may be prescribed to improve blood sugar control along with diet and exercise. It also has approved uses related to certain heart and kidney risks in eligible adults with type 2 diabetes.
Ozempic is not FDA-approved specifically for chronic weight management. Some clinicians may prescribe it off-label when medically appropriate, but insurance coverage and eligibility can vary. It is usually given as a once-weekly injection through a prefilled pen.
What Is Wegovy?
Wegovy is an FDA-approved semaglutide medication for chronic weight management in eligible adults and certain adolescents. It is used with a reduced-calorie eating plan and increased physical activity. It also has other approved uses for specific eligible patients.
Wegovy injection is typically started at a low weekly dose and increased gradually. This step-by-step schedule may help the body adjust and may reduce digestive side effects. The maintenance dose and treatment plan can differ from Ozempic, even though both medications contain semaglutide.
What Is Compounded Semaglutide?
Compounded semaglutide is made by a compounding pharmacy based on a prescription. Compounding may be appropriate in limited situations when a patient has a medical need that cannot be met by an available FDA-approved product. Federal and state rules affect when compounded versions may be prepared or prescribed.
A compounded medication is not reviewed or approved by the FDA for safety, effectiveness, or manufacturing quality before it reaches patients. It is also not automatically a generic version of Ozempic or Wegovy.
Why Pharmacy Quality Matters
Compounded semaglutide may come in a vial instead of a prefilled pen. Concentrations can differ between pharmacies, so patients need clear instructions showing the exact dose in milligrams and the correct amount to draw into a syringe. The FDA has reported dosing errors with some compounded semaglutide products, including confusion between milligrams, milliliters, and syringe units.
The FDA has also warned against compounded products made with semaglutide sodium or semaglutide acetate. These salt forms are different active ingredients from the form used in FDA-approved semaglutide medications. Patients should ask which form is being used, where the prescription is filled, and how the dose should be measured.
Ozempic vs Wegovy vs Compounded Semaglutide
- Active ingredient: Ozempic and Wegovy contain semaglutide. A properly prescribed compounded product should be reviewed carefully to confirm its ingredients and form.
- FDA approval: Ozempic and Wegovy are FDA-approved products. Compounded semaglutide is not FDA-approved.
- Primary approved use: Ozempic is mainly approved for adults with type 2 diabetes. Wegovy is approved for chronic weight management in eligible patients and for certain other uses.
- Delivery: Brand-name injections commonly use prefilled devices. Compounded medication may be supplied in a vial that requires careful measurement.
- Coverage and cost: Insurance rules, pharmacy benefits, eligibility, and availability may affect each option.
- Medical oversight: Every option requires a prescription, health screening, dose guidance, and follow-up care.
What Side Effects and Risks Should You Discuss?
Semaglutide may cause nausea, vomiting, diarrhea, constipation, stomach pain, or reduced appetite. More serious risks may include pancreatitis, gallbladder problems, kidney injury related to dehydration, severe digestive reactions, and low blood sugar when combined with certain diabetes medicines.
Semaglutide products carry a boxed warning about thyroid C-cell tumors seen in animal studies. They should not be used by people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Tell your provider about pregnancy plans, past pancreatitis, digestive problems, kidney concerns, and every medication or supplement you use.
How Do You Choose the Right Option?
Start with a medical evaluation, not a product preference. A provider should review your health history, current medications, lab results, goals, and possible reasons for a GLP-1 plateau or weight regain. Made Ya Skinny offers physician-guided semaglutide and tirzepatide care, blood lab optimization, functional medicine, BHRT, invisa-RED red light therapy, and telehealth visits. Made Ya Skinny prescribes appropriate medication but does not sell it. Care is available in Magnolia and Cypress, serving The Woodlands, Conroe, Willis, Montgomery, North Houston, Tomball, and eligible telehealth patients in multiple states.
Your first visit is just $17. Book online at madeyaskinny.com.